We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+2.42%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$29.6B
AUM Growth
+$1.62B
Cap. Flow
+$1.32B
Cap. Flow %
4.47%
Top 10 Hldgs %
15.49%
Holding
3,030
New
705
Increased
1,212
Reduced
975
Closed
103

Top Buys

Rank Stock Value
1
VOO icon
Vanguard S&P 500 ETF
VOO
+$132M
2
AGG icon
iShares Core US Aggregate Bond ETF
AGG
+$99.6M
3
EFA icon
iShares MSCI EAFE ETF
EFA
+$74.4M
4
VCIT icon
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
+$61M
5
ABBV icon
AbbVie
ABBV
+$57.3M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$147M
2
EWJ icon
iShares MSCI Japan ETF
EWJ
+$64.8M
3
BRCM
BROADCOM CORP CL-A
BRCM
+$56.9M
4
MINT icon
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
+$53.9M
5
DBEF icon
Xtrackers MSCI EAFE Hedged Equity ETF
DBEF
+$38M

Sector Composition

Rank Sector Weight
1 Healthcare 9.02%
2 Technology 8.84%
3 Financials 8.13%
4 Consumer Staples 8.02%
5 Industrials 7.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BMY icon
2851
CALL
Bristol-Myers Squibb
BMY
$132B
$19K ﹤0.01%
+47,300
New +$2.98M
NKE icon
2852
CALL
Nike
NKE
$61.9B
$19K ﹤0.01%
+12,000
New +$725K
PWE
2853
DELISTED
Penn West Energy Petroleum Ltd
PWE
$19K ﹤0.01%
+20,352
New +$17.4K
RXII
2854
DELISTED
GALENA BIOPHARMA INC COM
RXII
$19K ﹤0.01%
+14,085
New +$19K
SNOA icon
2855
Sonoma Pharmaceuticals
SNOA
$6.89M
$18K ﹤0.01%
+21
New +$19.5K
BNFT
2856
CALL
DELISTED
Benefitfocus, Inc.
BNFT
$18K ﹤0.01%
+15,400
New +$459K
ECT
2857
DELISTED
ECA Marcellus Trust 1 Interest
ECT
$18K ﹤0.01%
+12,701
New +$15.2K
BA icon
2858
CALL
Boeing
BA
$185B
$17K ﹤0.01%
+13,000
New +$1.61M
BAC icon
2859
CALL
Bank of America
BAC
$442B
$16K ﹤0.01%
+10,400
New +$140K
NAVB
2860
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
$16K ﹤0.01%
+850
New +$16.4K
PVCT
2861
DELISTED
PROVECTUS BIOPHARMACEUTICALS, INC. (DE)
PVCT
$16K ﹤0.01%
+41,620
New +$17.1K
SQI
2862
CALL
DELISTED
SCIQUEST, INC. COMMON STOCK
SQI
$16K ﹤0.01%
+29,400
New +$371K
MBLY
2863
CALL
DELISTED
Mobileye N.V.
MBLY
$15K ﹤0.01%
+17,800
New +$567K
EMR icon
2864
CALL
Emerson Electric
EMR
$88.3B
$14K ﹤0.01%
+17,700
New +$854K
OSUR icon
2865
CALL
OraSure Technologies
OSUR
$279M
$14K ﹤0.01%
+17,000
New +$108K
CMLS
2866
DELISTED
Cumulus Media Inc. Class A Common Stock
CMLS
$14K ﹤0.01%
+3,902
New +$10.2K
ARP
2867
DELISTED
ATLAS RESOURCE PARTNERS L P COM UIT REPSTG LTD PTNRS
ARP
$14K ﹤0.01%
+17,877
New +$13.9K
DAL icon
2868
CALL
Delta Air Lines
DAL
$60.1B
$13K ﹤0.01%
+11,900
New +$556K
LVS icon
2869
CALL
Las Vegas Sands
LVS
$29.6B
$13K ﹤0.01%
+13,800
New +$632K
GEN icon
2870
CALL
Gen Digital
GEN
$17.5B
$12K ﹤0.01%
+19,900
New +$383K
RSG icon
2871
CALL
Republic Services
RSG
$65.7B
$12K ﹤0.01%
+14,900
New +$676K
TRNX
2872
DELISTED
Taronis Technologies, Inc. Common Stock
TRNX
$12K ﹤0.01%
+1
New +$18.5K
CAH icon
2873
CALL
Cardinal Health
CAH
$55.4B
$11K ﹤0.01%
+42,200
New +$3.43M
UNP icon
2874
CALL
Union Pacific
UNP
$174B
$11K ﹤0.01%
+11,500
New +$889K
CDMO
2875
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$11K ﹤0.01%
+3,579
New +$19.2K
113 114
115
116 117

Similar funds

RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
PI
PEAK6 Investments Chicago, Illinois $44.8B AUM 19.99% 1-Year Est. Return
ECU
Eisler Capital (UK) London, United Kingdom $21.7B AUM 0.34% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
AA
Axiom Advisory San Diego, California $10.7B AUM 25.51% 1-Year Est. Return
SA
SpiderRock Advisors Wilimington, Delaware $6.29B AUM
WPL
Winder Pte Ltd Singapore $5.59B AUM 41.5% 1-Year Est. Return
ECU
Eisler Capital (US) New York $4.67B AUM 35.2% 1-Year Est. Return

Raymond James & Associates's Q1 2016 Portfolio in Review

As of Q1 2016, Raymond James & Associates held 3,030 positions worth $29.6B, up 5.8% from $27.9B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Raymond James & Associates deployed $1.32B of net new capital in Q1 2016, opening 705 new positions and adding to 1,212 existing holdings. Its largest new stake was FlexShares Quality Dividend Index Fund: 874,910 shares worth $31.6M.

By sector, the portfolio is most concentrated in Healthcare at 9% of assets, down from 9.6% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $147M trimmed.

  • Raymond James & Associates's largest Q1 2016 buy was FlexShares Quality Dividend Index Fund: 874,910 shares worth $31.6M.
  • Raymond James & Associates added most to Vanguard S&P 500 ETF in Q1 2016, an estimated $132M increase.
  • Raymond James & Associates's biggest Q1 2016 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $147M.
  • Raymond James & Associates fully exited BROADCOM CORP CL-A in Q1 2016, selling an estimated $56.9M.
  • Raymond James & Associates's ten largest holdings make up 15% of its $29.6B portfolio in Q1 2016.
  • Raymond James & Associates opened 705 new positions and closed 103 in Q1 2016.
  • Raymond James & Associates's portfolio value rose 5.8% quarter-over-quarter to $29.6B.

Based on Raymond James & Associates's 13F filing for Q1 2016, filed 12 May 2016.